Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury.

Lange T, Artelt N, Kindt F, Stracke S, Rettig R, Lendeckel U, Chadjichristos CE, Kavvadas P, Chatziantoniou C, Endlich K, Endlich N.

J Cell Mol Med. 2019 Jul;23(7):4839-4843. doi: 10.1111/jcmm.14317. Epub 2019 May 7. No abstract available.

3.

Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease.

Prakoura N, Kavvadas P, Chadjichristos CE.

Cell Physiol Biochem. 2018;49(3):985. doi: 10.1159/000493230. Epub 2018 Sep 7. Review.

4.

The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Rizou M, Frangou EA, Marineli F, Prakoura N, Zoidakis J, Gakiopoulou H, Liapis G, Kavvadas P, Chatziantoniou C, Makridakis M, Vlahou A, Boletis J, Vlahakos D, Goumenos D, Daphnis E, Iatrou C, Charonis AS.

J Cell Mol Med. 2018 Sep;22(9):4139-4149. doi: 10.1111/jcmm.13691. Epub 2018 Jun 28.

5.

Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.

Kavvadas P, Keuylian Z, Prakoura N, Placier S, Dorison A, Chadjichristos CE, Dussaule JC, Chatziantoniou C.

Kidney Int. 2018 Jul;94(1):126-138. doi: 10.1016/j.kint.2018.01.031. Epub 2018 May 8.

PMID:
29751972
6.

The Role of Palladin in Podocytes.

Artelt N, Ludwig TA, Rogge H, Kavvadas P, Siegerist F, Blumenthal A, van den Brandt J, Otey CA, Bang ML, Amann K, Chadjichristos CE, Chatziantoniou C, Endlich K, Endlich N.

J Am Soc Nephrol. 2018 Jun;29(6):1662-1678. doi: 10.1681/ASN.2017091039. Epub 2018 May 2.

7.

Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN.

Kavvadas P, Abed A, Poulain C, Authier F, Labéjof LP, Calmont A, Afieri C, Prakoura N, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

J Am Soc Nephrol. 2017 Oct;28(10):2915-2930. doi: 10.1681/ASN.2016111211. Epub 2017 Jun 30.

8.

NFκB-Induced Periostin Activates Integrin-β3 Signaling to Promote Renal Injury in GN.

Prakoura N, Kavvadas P, Kormann R, Dussaule JC, Chadjichristos CE, Chatziantoniou C.

J Am Soc Nephrol. 2017 May;28(5):1475-1490. doi: 10.1681/ASN.2016070709. Epub 2016 Dec 5.

9.

Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases.

Arvaniti E, Moulos P, Vakrakou A, Chatziantoniou C, Chadjichristos C, Kavvadas P, Charonis A, Politis PK.

Sci Rep. 2016 May 18;6:26235. doi: 10.1038/srep26235.

10.

Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.

Marchal PO, Kavvadas P, Abed A, Kazazian C, Authier F, Koseki H, Hiraoka S, Boffa JJ, Martinerie C, Chadjichristos CE.

PLoS One. 2015 Sep 14;10(9):e0137876. doi: 10.1371/journal.pone.0137876. eCollection 2015.

11.

Searching novel diagnostic markers and targets for therapy of CKD.

Kavvadas P, Dussaule JC, Chatziantoniou C.

Kidney Int Suppl (2011). 2014 Nov;4(1):53-57. Review.

12.

Functional roles of connexins and pannexins in the kidney.

Abed AB, Kavvadas P, Chadjichristos CE.

Cell Mol Life Sci. 2015 Aug;72(15):2869-77. doi: 10.1007/s00018-015-1964-5. Epub 2015 Jun 17. Review.

PMID:
26082183
13.

Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Alfieri C, Kavvadas P, Simonini P, Ikehata M, Dussaule JC, Chadjichristos CE, Rastaldi MP, Messa P, Chatziantoniou C.

Nephrol Dial Transplant. 2015 Dec;30(12):1965-71. doi: 10.1093/ndt/gfv074. Epub 2015 Mar 31. Review.

14.

Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.

El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2015 Jul;26(7):1561-75. doi: 10.1681/ASN.2013090968. Epub 2014 Nov 24.

15.

Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice.

Abed A, Toubas J, Kavvadas P, Authier F, Cathelin D, Alfieri C, Boffa JJ, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Kidney Int. 2014 Oct;86(4):768-79. doi: 10.1038/ki.2014.108. Epub 2014 May 21.

16.

Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.

Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C.

Hypertension. 2013 Apr;61(4):901-7. doi: 10.1161/HYPERTENSIONAHA.111.00639. Epub 2013 Feb 25.

PMID:
23438929
17.

The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease.

Huby AC, Kavvadas P, Alfieri C, Abed A, Toubas J, Rastaldi MP, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

PLoS One. 2012;7(12):e52362. doi: 10.1371/journal.pone.0052362. Epub 2012 Dec 26.

18.

Progression of renal fibrosis: the underestimated role of endothelial alterations.

Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S15. doi: 10.1186/1755-1536-5-S1-S15. eCollection 2012.

19.

Renal fibrosis: insight from proteomics in animal models and human disease.

Klein J, Kavvadas P, Prakoura N, Karagianni F, Schanstra JP, Bascands JL, Charonis A.

Proteomics. 2011 Feb;11(4):805-15. doi: 10.1002/pmic.201000380. Epub 2011 Jan 13. Review. Erratum in: Proteomics. 2011 Jun;11(11):2359.

PMID:
21229585
20.

Integrin-linked kinase (ILK) in pulmonary fibrosis.

Kavvadas P, Kypreou KP, Protopapadakis E, Prodromidi E, Sideras P, Charonis AS.

Virchows Arch. 2010 Nov;457(5):563-75. doi: 10.1007/s00428-010-0976-7. Epub 2010 Sep 21.

PMID:
20857141
21.

ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells.

Alberti A, Karamessinis P, Peroulis M, Kypreou K, Kavvadas P, Pagakis S, Politis PK, Charonis A.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E812-21. doi: 10.1152/ajpendo.00053.2009. Epub 2009 Jul 21.

22.

Altered expression of calreticulin during the development of fibrosis.

Kypreou KP, Kavvadas P, Karamessinis P, Peroulis M, Alberti A, Sideras P, Psarras S, Capetanaki Y, Politis PK, Charonis AS.

Proteomics. 2008 Jun;8(12):2407-19. doi: 10.1002/pmic.200700831.

PMID:
18563736

Supplemental Content

Loading ...
Support Center